Abstract
Aims
CXXC finger protein 4 (CXXC4) is an identified negative regulator of the Wnt/β-catenin pathway, and it is involved in cancer cell proliferation. In this study, we sought to clarify whether CXXC4 is involved in glucose-stimulated β-cell proliferation.
Materials and methods
We investigated the biological function of CXXC4 in glucose-induced β-cell proliferation, and we investigated the underlying mechanism of this activity. First, we analyzed CXXC4 expression in established rat models treated for 24 h with a high glucose infusion and in INS-1 cells and primary rat islets treated with different concentrations of glucose. Subsequently, we used an adenovirus to overexpress CXXC4 in INS-1 cells and primary islets. The proliferation rate of β-cells was evaluated by CCK-8 and EdU incorporation methods. Cell cycle analysis was performed by flow cytometry. Finally, the Wnt signaling pathway and its downstream genes were assessed by Western blot.
Results
CXXC4 mRNA levels were significantly lower in islets isolated from glucose-infused rats than they were in those isolated from saline-infused rats. Decreased expression of CXXC4 also correlated with high glucose treatment of INS-1 cells and primary rat β-cells. Furthermore, adenovirus-mediated overexpression of CXXC4 inhibited cell proliferation induced by the high glucose treatment in vitro, which was mechanistically mediated by Wnt signaling and a decrease in cyclin D2 expression.
Conclusions
Glucose inhibits CXXC4 expression and hence promotes pancreatic β-cell proliferation. Our findings may provide a new potential target for the treatment of diabetes.
Similar content being viewed by others
References
Mezza T, Cinti F, Cefalo CMA, Pontecorvi A, Kulkarni RN, Giaccari A (2019) Beta-cell fate in human insulin resistance and type 2 diabetes: a perspective on islet plasticity. Diabetes 68(6):1121–1129. https://doi.org/10.2337/db18-0856
Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47(3):581–589. https://doi.org/10.1007/s00125-004-1336-4
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52(1):102–110. https://doi.org/10.2337/diabetes.52.1.102
Lee YC, Nielsen JH (2009) Regulation of beta cell replication. Mol Cell Endocrinol 297(1–2):18–27. https://doi.org/10.1016/j.mce.2008.08.033
Kulkarni RN (2005) New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass. Rev Endocr Metab Disord 6(3):199–210. https://doi.org/10.1007/s11154-005-3051-y
Nielsen JH, Galsgaard ED, Moldrup A et al (2001) Regulation of beta-cell mass by hormones and growth factors. Diabetes 50(Suppl 1):S25–29. https://doi.org/10.2337/diabetes.50.2007.s25
Swenne I (1982) The role of glucose in the in vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic B-cells. Diabetes 31(9):754–760. https://doi.org/10.2337/diab.31.9.754
Bonner-Weir S, Deery D, Leahy JL, Weir GC (1989) Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38(1):49–53. https://doi.org/10.2337/diab.38.1.4
Bernard C, Thibault C, Berthault MF et al (1998) Pancreatic beta-cell regeneration after 48-h glucose infusion in mildly diabetic rats is not correlated with functional improvement. Diabetes 47(7):1058–1065. https://doi.org/10.2337/diabetes.47.7.1058
Elghazi L, Balcazar N, Bernal-Mizrachi E (2006) Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function. Int J Biochem Cell Biol 38(2):157–163. https://doi.org/10.1016/j.biocel.2005.08.017
Hino S, Kishida S, Michiue T et al (2001) Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol Cell Biol 21(1):330–342. https://doi.org/10.1128/MCB.21.1.330-342.2001
Michiue T, Fukui A, Yukita A et al (2004) XIdax, an inhibitor of the canonical Wnt pathway, is required for anterior neural structure formation in Xenopus. Dev Dyn 230(1):79–90. https://doi.org/10.1002/dvdy.20037
Kojima T, Shimazui T, Hinotsu S et al (2009) Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling. Oncogene 28(2):297–305. https://doi.org/10.1038/onc.2008.391
Rulifson IC, Karnik SK, Heiser PW et al (2007) Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A 104(15):6247–6252. https://doi.org/10.1073/pnas.0701509104
Guan B, Li W, Li F et al (2016) Sfrp5 mediates glucose-induced proliferation in rat pancreatic beta-cells. J Endocrinol 229(2):73–83. https://doi.org/10.1530/JOE-15-0535
Chocarro-Calvo A, Garcia-Martinez JM, Ardila-Gonzalez S, De la Vieja A, Garcia-Jimenez C (2013) Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer. Mol Cell 49(3):474–486. https://doi.org/10.1016/j.molcel.2012.11.022
Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429(6987):41–46. https://doi.org/10.1038/nature02520
Teta M, Rankin MM, Long SY, Stein GM, Kushner JA (2007) Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 12(5):817–826. https://doi.org/10.1016/j.devcel.2007.04.011
Bernard C, Berthault MF, Saulnier C, Ktorza A (1999) Neogenesis vs apoptosis as main components of pancreatic beta cell mass changes in glucose-infused normal and mildly diabetic adult rats. FASEB J. 13(10):1195–1205. https://doi.org/10.1096/fasebj.13.10.1195
Lu H, Sun J, Wang F et al (2013) Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4. Cell Death Dis 4:e776. https://doi.org/10.1038/cddis.2013.293
Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810. https://doi.org/10.1146/annurev.cellbio.20.010403.113126
Georgia S, Bhushan A (2004) Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114(7):963–968. https://doi.org/10.1172/JCI22098
Kushner JA, Ciemerych MA, Sicinska E et al (2005) Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 25(9):3752–3762. https://doi.org/10.1128/MCB.25.9.3752-3762.2005
Lu H, Jin W, Sun J et al (2014) New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling. FEBS Lett 588(18):3322–3326. https://doi.org/10.1016/j.febslet.2014.07.014
Wang R, Bouwens L, Klöppel G (1996) Beta cell growth in adolescent and adult rats treated with streptozotocin during the neonatal period. Diabetologia 39(5):548–557. https://doi.org/10.1007/bf00403301
Tyrberg B, Eizirik D, Hellerstrom C, Pipeleers D, Andersson A (1996) Human pancreatic beta-cell deoxyribonucleic acid-synthesis in islet grafts decreases with increasing organ donor age but increases in response to glucose stimulation in vitro. Endocrinology 137(12):5694–5699. https://doi.org/10.1210/endo.137.12.8940401
Acknowledgements
We thank Dr. Hongli Zhang (No. 7 Hospital, Shanghai) and Dr. Wenyi Li (Ruijin Hospital, Shanghai) for their excellent technical assistance. This work was supported by the Natural Science Foundation of Fujian (2017Y9047, 2016J01547) and the Foundation of Fujian Provincial Health Commission (2018ZQN32).
Author information
Authors and Affiliations
Contributions
B G and Z Z were responsible for the collection of data, data assembly, data analysis, interpretation, and manuscript writing. LX W and LJ W were responsible for data collection and contributed to the discussion. B G and L L were responsible for the conception, manuscript revision, and financial support. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial conflicts of interest.
Ethical approval
All procedures were performed in accordance with the principles of the Guide for the Care and Use of Experimental Animals of Fujian Medical University and were approved by the Animal Care Committee at Fujian Medical University.
Informed consent
For this type of study, no informed consent is required.
Additional information
Managed By Massimo Federici.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Guan, B., Zhan, Z., Wang, L. et al. CXXC4 mediates glucose-induced β-cell proliferation. Acta Diabetol 57, 1101–1109 (2020). https://doi.org/10.1007/s00592-020-01525-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-020-01525-5